What is the relapse rate for advanced stage 4 nodular sclerosis Hodgkin lymphoma patients who have completed 6 rounds of Nivo-AVD chemotherapy?
Unfortunately, specific relapse rate data for Nivo-AVD treatment isn't available in the current information. This is a newer treatment regimen, and comprehensive long-term data on Show Full Answer
What is the relapse rate for advanced stage 4 nodular sclerosis Hodgkin lymphoma patients who have completed 6 rounds of Nivo-AVD chemotherapy?
Unfortunately, specific relapse rate data for Nivo-AVD treatment isn't available in the current information. This is a newer treatment regimen, and comprehensive long-term data on relapse rates may still be emerging.
What we do know is that advanced stage Hodgkin lymphoma (stages 3 and 4) generally has a favorable outlook. The five-year survival rate for stage 4 Hodgkin lymphoma is about 78.5 percent, which is quite encouraging.
For advanced-stage Hodgkin lymphoma, doctors typically recommend aggressive treatment plans with multiple rounds of chemotherapy, often six cycles. The prognosis depends on several risk factors including:
- Age (45 or older)
- Gender (male)
- Low albumin levels
- Low hemoglobin levels
- High white blood cell counts
- Low lymphocyte levels
Even when Hodgkin lymphoma does recur, there are treatment options available including immunotherapy drugs and stem cell transplants. Your oncologist can provide more specific information about relapse rates based on your individual case and the latest clinical data for Nivo-AVD.
December 28, 2025